Biotech IPO Surge a Shot in the Arm for Hong Kong

As Hong Kong’s capital markets continue to have a strong year, one trend has been clear: The growing number of listings by Chinese biotech and biopharma companies. The past few weeks have seen a ... ( read original story ...)